Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...

Medtronic (NYSE: MDT) says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with hypertension.

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...

While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now ...

Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its medical device. The ...